A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial

199-OR: Improved Glycemic Outcomes with Medtronic Minimed Advanced Hybrid Closed-Loop Delivery: Results from a Randomized Crossover Trial Comparing Automated Insulin Delivery with Predictive Low Glucose Suspend in People with Type 1 Diabetes

(2020) OLIVIA COLLYNS et al.   DIABETES

97-LB: Safety and Glycemic Outcomes of the MiniMed Advanced Hybrid Closed-Loop (AHCL) System in Subjects with T1D

(2020) ANDERS L. CARLSON et al.   DIABETES

A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes

(2020) Marc D. Breton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop Trial

(2020) Elvira Isganaitis et al.   Diabetes Technology & Therapeutics

Advanced Technology in the Management of Diabetes: Which Comes First—Continuous Glucose Monitor or Insulin Pump?

(2019) Christopher T. Martin et al.   Current Diabetes Reports

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

(2019) Tadej Battelino et al.   DIABETES CARE

One Year Clinical Experience of the First Commercial Hybrid Closed-Loop

(2019) Rayhan A. Lal et al.   DIABETES CARE

Advances in technology for management of type 1 diabetes

(2019) Roy W Beck et al.   LANCET

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

(2019) Sue A. Brown et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increased proportion of time in hybrid closed‐loop “Auto Mode” is associated with improved glycaemic control for adolescent and young patients with adult type 1 diabetes using the MiniMed 670G insulin pump

(2019) Sara H. Duffus et al.   DIABETES OBESITY & METABOLISM

Long‐term real‐life glycaemic outcomes with a hybrid closed‐loop system compared with sensor‐augmented pump therapy in patients with type 1 diabetes

(2019) Halis Kaan Akturk et al.   DIABETES OBESITY & METABOLISM

Six months of hybrid closed loop in the real‐world: An evaluation of children and young adults using the 670G system

(2019) Cari Berget et al.   PEDIATRIC DIABETES

Real world hybrid closed‐loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months

(2019) Laurel H. Messer et al.   PEDIATRIC DIABETES

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials

(2018) Roy W. Beck et al.   DIABETES CARE

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial

(2018) Martin Tauschmann et al.   LANCET

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

(2016) Richard M. Bergenstal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Development of a New Measure for Assessing Glucose Monitoring Device-Related Treatment Satisfaction and Quality of Life

(2015) William H. Polonsky et al.   Diabetes Technology & Therapeutics

MD-Logic Overnight Control for 6 Weeks of Home Use in Patients With Type 1 Diabetes: Randomized Crossover Trial

(2014) Revital Nimri et al.   DIABETES CARE

Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp

(2013) Moshe Phillip et al.   NEW ENGLAND JOURNAL OF MEDICINE

MD-Logic Artificial Pancreas System: A pilot study in adults with type 1 diabetes

(2010) E. Atlas et al.   DIABETES CARE